Lisa Field
Payments from drug & device makers
Across 72 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$389
- Pfizer$175
- Bristol Myers Squibb$151
- Sanofi$117
- Nestle Healthcare Nutrition Inc.$99
- Intercept Pharmaceuticals, Inc.$93
- plus $321 from 10 others
What the payments were for
- Food & beverage$1,26894%
- Education$766%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $389 |
| Pfizer | 18 | $175 |
| Bristol Myers Squibb | 7 | $151 |
| Sanofi | 5 | $117 |
| Nestle Healthcare Nutrition Inc. | 5 | $99 |
| Intercept Pharmaceuticals, Inc. | 4 | $93 |
| Johnson & Johnson | 1 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 1 | $45 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
How this compares
$1,344 in reported general payments places this provider in the 85th percentile of 1,130 family providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide DrBudesonide | 13 | $936 |
| Omeprazole | 44 | $868 |
| Pantoprazole Sodium | 41 | $838 |
| Tramadol Hcl | 88 | $297 |
| Famotidine | 11 | $159 |
| Amoxicillin | 98 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $120 |
| Meloxicam | 24 | $96 |
| Methocarbamol | 15 | $76 |
| Hydromorphone Hcl | 30 | $69 |
| Clindamycin Hcl | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other family in Bend
- Elyssa FosterBend$14K
- Tonya KoopmanBend$7K
- Matthew BerrymanBend$5K
- Kendra OwensBend$4K
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- David ArnopoleMedford$38K
- Heather HermanCorvallis$34K
- Amy BartramOregon City$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.